Cardiopulmonary Corp., which provides real-time connected healthcare, and Nuvon, a medical device integration, interoperability and clinical intelligence company, will merge.

Each company's board of directors has approved the terms of the proposed transaction, which is expected to close in the next 60 days. The financial terms of the deal were not disclosed.

CPC and Nuvon executives say both companies bring complementary capabilities that can be seamlessly integrated and have the strong forward-looking support of their well-capitalized investors.

The combined company will offer a platform that provides enterprise-wide, real-time data management solutions to enable clinical insight for better patient care and support of critical healthcare workflows. Nuvon brings a strong and growing medical device integration platform, and CPC's Bernoulli platform supports advanced alarm management, Continuous patient monitoring/surveillance and virtual ICU applications. Both companies have also been doing work in the area of predictive analytics, and they will be aligning those initiatives.

[See also: 5 ways device integration increases the value of data in an EMR]

"Nuvon and CPC have a shared vision of leveraging comprehensive, high-fidelity, real time data to provide clinical insight across the all levels of patient acuity and the continuum of care," said Janet Dillione, CEO of CPC, in a news release. "Both companies have been working on the very difficult tasks of capturing and adding value to disparate real-time data for more than a decade, and agree that a merger which brings together our employees, interoperable solutions and nationally recognized clients represents the best way to move forward."

[See also: MDI market eyes promising future.]

"Our mission has been to transform medicine by delivering critical patient care data at the point of care, anywhere and in any format," added Nuvon CEO Christopher Gatti. "We are absolutely confident that by joining together with CPC we will be able to further advance that mission and bring additional value across the entire patient care spectrum to both our current and future clients."